US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist
  • 7.060
  • -0.160-2.22%
Close Dec 27 16:00 ET
  • 7.400
  • +0.340+4.82%
Post 20:01 ET
433.74MMarket Cap-3.97P/E (TTM)

Monte Rosa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.02%-20.99M
-9.65%-27.77M
-63.06%-38.17M
52.63%-43.8M
223.68%29.63M
-19.93%-24.71M
-23.53%-25.32M
14.59%-23.41M
-55.76%-92.47M
-69.07%-23.96M
Net income from continuing operations
31.60%-23.86M
13.84%-30.31M
0.22%-31.97M
-24.75%-135.35M
-8.02%-33.25M
-27.70%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
Operating gains losses
----
----
----
198.17%107K
--0
--0
---24K
204.80%131K
-741.18%-109K
--0
Depreciation and amortization
14.67%2.1M
48.09%2.06M
64.81%1.9M
66.14%6.22M
72.52%1.85M
77.54%1.83M
56.47%1.39M
52.86%1.15M
75.66%3.75M
32.26%1.07M
Other non cash items
----
----
----
----
----
----
----
----
401.46%4.81M
--1.61M
Change In working capital
-155.59%-2.43M
-150.89%-2.93M
-377.85%-12.9M
3,495.78%72.47M
2,683.55%57.7M
245.42%4.37M
374.26%5.75M
169.44%4.64M
-133.95%-2.13M
-68.59%2.07M
-Change in receivables
2,365.87%9.25M
-4,683.08%-9.33M
-100.49%-10K
1,114.44%1.9M
-3,260.00%-336K
311.86%375K
---195K
--2.05M
---187K
---10K
-Change in prepaid assets
-975.74%-2.53M
-106.70%-125K
-73.26%-2.29M
150.63%1.08M
15,400.00%765K
83.61%-235K
2,433.75%1.87M
-117.11%-1.32M
-202.13%-2.13M
-100.56%-5K
-Change in payables and accrued expense
-101.47%-51K
38.29%2.44M
-200.64%-8.96M
3,145.64%9.32M
216.88%7.06M
23.94%3.47M
76.30%1.76M
48.13%-2.98M
-95.12%287K
-51.60%2.23M
-Change in other working capital
-1,298.81%-9.1M
76.78%4.09M
-123.88%-1.65M
56,340.19%60.18M
36,227.34%50.22M
925.68%759K
692.12%2.31M
2,162.28%6.89M
-109.65%-107K
---139K
Cash from discontinued investing activities
Operating cash flow
15.02%-20.99M
-9.65%-27.77M
-63.06%-38.17M
52.63%-43.8M
223.68%29.63M
-19.93%-24.71M
-23.53%-25.32M
14.59%-23.41M
-55.76%-92.47M
-69.07%-23.96M
Investing cash flow
Cash flow from continuing investing activities
5.95%37.75M
-429.69%-61.16M
-51.53%9.85M
140.51%88.8M
126.51%14.3M
20.82%35.63M
230.18%18.55M
111.26%20.33M
-2,170.99%-219.22M
-1,670.23%-53.94M
Net PPE purchase and sale
75.95%-399K
68.65%-2.02M
84.93%-1.38M
-48.25%-18.98M
76.77%-1.69M
-17.16%-1.66M
-152.64%-6.45M
-487.77%-9.18M
-32.62%-12.8M
-138.63%-7.27M
Net investment purchase and sale
2.31%38.15M
-336.54%-59.14M
-61.92%11.24M
152.21%107.78M
134.25%15.99M
20.65%37.29M
313.75%25M
116.49%29.51M
---206.42M
---46.67M
Cash from discontinued investing activities
Investing cash flow
5.95%37.75M
-429.69%-61.16M
-51.53%9.85M
140.51%88.8M
126.51%14.3M
20.82%35.63M
230.18%18.55M
111.26%20.33M
-2,170.99%-219.22M
-1,670.23%-53.94M
Financing cash flow
Cash flow from continuing financing activities
-98.64%15K
8,068.58%98.02M
1,266.67%246K
34.33%27.49M
23.19%25.17M
607.37%1.1M
1,150.00%1.2M
-88.24%18K
-94.58%20.47M
15,236.30%20.43M
Net common stock issuance
---641K
----
----
--0
--0
--0
----
----
-91.56%20.06M
----
Proceeds from stock option exercised by employees
-98.64%15K
4,126.58%50.72M
1,266.67%246K
3,462.32%27.61M
5,557.49%25.29M
1,293.67%1.1M
1,150.00%1.2M
-88.24%18K
420.13%775K
2,028.57%447K
Net other financing activities
----
----
----
68.13%-116K
----
----
----
----
89.09%-364K
56.41%-68K
Cash from discontinued financing activities
Financing cash flow
-98.64%15K
8,068.58%98.02M
1,266.67%246K
34.33%27.49M
23.19%25.17M
607.37%1.1M
1,150.00%1.2M
-88.24%18K
-94.58%20.47M
15,236.30%20.43M
Net cash flow
Beginning cash position
120.57%113.71M
83.12%104.62M
120.44%132.68M
-82.87%60.19M
-45.96%63.58M
-52.70%51.55M
-60.23%57.13M
-82.87%60.19M
719.84%351.41M
-68.09%117.66M
Current changes in cash
39.48%16.77M
263.22%9.1M
-816.59%-28.07M
124.89%72.49M
220.25%69.1M
38.64%12.02M
83.92%-5.57M
98.53%-3.06M
-194.38%-291.22M
-231.14%-57.47M
End cash Position
105.24%130.48M
120.57%113.71M
83.12%104.62M
120.44%132.68M
120.44%132.68M
-45.96%63.58M
-52.70%51.55M
-60.23%57.13M
-82.87%60.19M
-82.87%60.19M
Free cash flow
18.86%-21.39M
6.43%-29.79M
-21.36%-39.55M
40.36%-62.84M
189.48%27.95M
-19.84%-26.37M
-38.09%-31.84M
-12.02%-32.59M
-52.51%-105.38M
-81.25%-31.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.02%-20.99M-9.65%-27.77M-63.06%-38.17M52.63%-43.8M223.68%29.63M-19.93%-24.71M-23.53%-25.32M14.59%-23.41M-55.76%-92.47M-69.07%-23.96M
Net income from continuing operations 31.60%-23.86M13.84%-30.31M0.22%-31.97M-24.75%-135.35M-8.02%-33.25M-27.70%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M
Operating gains losses ------------198.17%107K--0--0---24K204.80%131K-741.18%-109K--0
Depreciation and amortization 14.67%2.1M48.09%2.06M64.81%1.9M66.14%6.22M72.52%1.85M77.54%1.83M56.47%1.39M52.86%1.15M75.66%3.75M32.26%1.07M
Other non cash items --------------------------------401.46%4.81M--1.61M
Change In working capital -155.59%-2.43M-150.89%-2.93M-377.85%-12.9M3,495.78%72.47M2,683.55%57.7M245.42%4.37M374.26%5.75M169.44%4.64M-133.95%-2.13M-68.59%2.07M
-Change in receivables 2,365.87%9.25M-4,683.08%-9.33M-100.49%-10K1,114.44%1.9M-3,260.00%-336K311.86%375K---195K--2.05M---187K---10K
-Change in prepaid assets -975.74%-2.53M-106.70%-125K-73.26%-2.29M150.63%1.08M15,400.00%765K83.61%-235K2,433.75%1.87M-117.11%-1.32M-202.13%-2.13M-100.56%-5K
-Change in payables and accrued expense -101.47%-51K38.29%2.44M-200.64%-8.96M3,145.64%9.32M216.88%7.06M23.94%3.47M76.30%1.76M48.13%-2.98M-95.12%287K-51.60%2.23M
-Change in other working capital -1,298.81%-9.1M76.78%4.09M-123.88%-1.65M56,340.19%60.18M36,227.34%50.22M925.68%759K692.12%2.31M2,162.28%6.89M-109.65%-107K---139K
Cash from discontinued investing activities
Operating cash flow 15.02%-20.99M-9.65%-27.77M-63.06%-38.17M52.63%-43.8M223.68%29.63M-19.93%-24.71M-23.53%-25.32M14.59%-23.41M-55.76%-92.47M-69.07%-23.96M
Investing cash flow
Cash flow from continuing investing activities 5.95%37.75M-429.69%-61.16M-51.53%9.85M140.51%88.8M126.51%14.3M20.82%35.63M230.18%18.55M111.26%20.33M-2,170.99%-219.22M-1,670.23%-53.94M
Net PPE purchase and sale 75.95%-399K68.65%-2.02M84.93%-1.38M-48.25%-18.98M76.77%-1.69M-17.16%-1.66M-152.64%-6.45M-487.77%-9.18M-32.62%-12.8M-138.63%-7.27M
Net investment purchase and sale 2.31%38.15M-336.54%-59.14M-61.92%11.24M152.21%107.78M134.25%15.99M20.65%37.29M313.75%25M116.49%29.51M---206.42M---46.67M
Cash from discontinued investing activities
Investing cash flow 5.95%37.75M-429.69%-61.16M-51.53%9.85M140.51%88.8M126.51%14.3M20.82%35.63M230.18%18.55M111.26%20.33M-2,170.99%-219.22M-1,670.23%-53.94M
Financing cash flow
Cash flow from continuing financing activities -98.64%15K8,068.58%98.02M1,266.67%246K34.33%27.49M23.19%25.17M607.37%1.1M1,150.00%1.2M-88.24%18K-94.58%20.47M15,236.30%20.43M
Net common stock issuance ---641K----------0--0--0---------91.56%20.06M----
Proceeds from stock option exercised by employees -98.64%15K4,126.58%50.72M1,266.67%246K3,462.32%27.61M5,557.49%25.29M1,293.67%1.1M1,150.00%1.2M-88.24%18K420.13%775K2,028.57%447K
Net other financing activities ------------68.13%-116K----------------89.09%-364K56.41%-68K
Cash from discontinued financing activities
Financing cash flow -98.64%15K8,068.58%98.02M1,266.67%246K34.33%27.49M23.19%25.17M607.37%1.1M1,150.00%1.2M-88.24%18K-94.58%20.47M15,236.30%20.43M
Net cash flow
Beginning cash position 120.57%113.71M83.12%104.62M120.44%132.68M-82.87%60.19M-45.96%63.58M-52.70%51.55M-60.23%57.13M-82.87%60.19M719.84%351.41M-68.09%117.66M
Current changes in cash 39.48%16.77M263.22%9.1M-816.59%-28.07M124.89%72.49M220.25%69.1M38.64%12.02M83.92%-5.57M98.53%-3.06M-194.38%-291.22M-231.14%-57.47M
End cash Position 105.24%130.48M120.57%113.71M83.12%104.62M120.44%132.68M120.44%132.68M-45.96%63.58M-52.70%51.55M-60.23%57.13M-82.87%60.19M-82.87%60.19M
Free cash flow 18.86%-21.39M6.43%-29.79M-21.36%-39.55M40.36%-62.84M189.48%27.95M-19.84%-26.37M-38.09%-31.84M-12.02%-32.59M-52.51%-105.38M-81.25%-31.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Advanced Micro Devices
AMD
+0.10%
ASML Holding
ASML
-0.32%
Meta Platforms
META
-0.59%
Cisco
CSCO
-0.62%
Intel
INTC
-0.68%

Unlock the Full List